NasdaqCM:RGCPharmaceuticals
Regencell Bioscience (RGC) Is Down 15.0% After DOJ Probe And Going Concern Disclosure - What's Changed
Regencell Bioscience Holdings, which focuses on Traditional Chinese Medicine for neurocognitive and immune-related disorders, recently disclosed in the past that it is cooperating with a U.S. Department of Justice investigation into trading activity in its shares, while reporting no revenue, a US$5.3 million net loss, and substantial doubt about its ability to continue as a going concern for the six months ended December 31, 2025.
This combination of regulatory scrutiny and limited financial...